lopinavir has been researched along with Malignant Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Abed, Y; Basile, MS; Cavalli, E; He, M; Maksimovic-Ivanic, D; Mazzon, E; Mijatovic, S; Nicoletti, F; Paskas, S; Rakocevic, S | 1 |
1 other study(ies) available for lopinavir and Malignant Melanoma
Article | Year |
---|---|
Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo.
Topics: Animals; Apoptosis; Autophagy; Cell Proliferation; Drug Hypersensitivity; Female; HIV Protease Inhibitors; Humans; In Vitro Techniques; Lopinavir; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Nitric Oxide; Reactive Oxygen Species; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |